Search research articles
Contact Us
Filters
Showing results (91-100 of 142) with videos related to
Page
of 15
Sort By:
Journal of Cellular Immunology
|
September 18, 2025
Modeling <i>TCIRG1</i> Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem Cells
Vahagn Makaryan, Merideth L Kelley, Audrey Anna Bolyard, et al.
Blood Advances
|
April 27, 2022
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
David C Dale, Audrey Anna Bolyard, James A Shannon, et al.
Experimental Hematology
|
May 24, 2003
Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia
Andrew A G Aprikyan, Tatyana Kutyavin, Steven Stein, et al.
Cancer Medicine
|
April 8, 2014
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study
Eva Culakova, Ramya Thota, Marek S Poniewierski, et al.
Blood
|
August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome
David C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 24, 2017
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim
David C Dale, Jeffrey Crawford, Zandra Klippel, et al.
Cytokine
|
February 10, 2015
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects
Nina Hastrup, Sauzanne Khalilieh, David C Dale, et al.
The New England Journal of Medicine
|
December 7, 2017
Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia
David C Dale, AudreyAnna Bolyard, Tracy Marrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens
Jennifer J Griggs, Eva Culakova, Melony E S Sorbero, et al.
Blood
|
February 7, 2004
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells
Göran Carlsson, Andrew A G Aprikyan, Ramin Tehranchi, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 142) with videos related to
Sort By:
Page
of 15
Journal of Cellular Immunology
|
September 18, 2025
Modeling <i>TCIRG1</i> Neutropenia by Utilizing Patient Derived Induced Pluripotent Stem Cells
Vahagn Makaryan, Merideth L Kelley, Audrey Anna Bolyard, et al.
Blood Advances
|
April 27, 2022
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
David C Dale, Audrey Anna Bolyard, James A Shannon, et al.
Experimental Hematology
|
May 24, 2003
Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia
Andrew A G Aprikyan, Tatyana Kutyavin, Steven Stein, et al.
Cancer Medicine
|
April 8, 2014
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study
Eva Culakova, Ramya Thota, Marek S Poniewierski, et al.
Blood
|
August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome
David C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 24, 2017
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim
David C Dale, Jeffrey Crawford, Zandra Klippel, et al.
Cytokine
|
February 10, 2015
The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects
Nina Hastrup, Sauzanne Khalilieh, David C Dale, et al.
The New England Journal of Medicine
|
December 7, 2017
Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia
David C Dale, AudreyAnna Bolyard, Tracy Marrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens
Jennifer J Griggs, Eva Culakova, Melony E S Sorbero, et al.
Blood
|
February 7, 2004
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells
Göran Carlsson, Andrew A G Aprikyan, Ramin Tehranchi, et al.
Page
of 15